Diamyd Medical AB (publ) (STO:DMYD.B)

Diamyd Medical AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is September - August.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 2, 2026	Aug 31, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021
Market Capitalization	2,018	1,554	1,637	840	1,122	2,412
Market Cap Growth	18.24%	-5.11%	94.98%	-25.12%	-53.50%	-11.83%
Enterprise Value	1,785	1,234	1,475	762	929	2,218
Last Close Price	14.68	11.30	16.42	9.79	14.24	32.90
PE Ratio	-	-	-	-	-	40.17
Forward PE	35.80	129.14	-	-	-	-
PS Ratio	5783.66	11951.90	12595.78	1538.11	2470.47	9533.21
PB Ratio	8.71	5.55	11.22	4.96	5.23	12.74
P/TBV Ratio	8.71	5.55	11.22	4.96	5.23	12.75
EV/Sales Ratio	-	9496.04	11346.68	1396.51	2045.78	8765.65
EV/FCF Ratio	-9.94	-	-	-	-	-
Net Debt / Equity Ratio	-1.01	-0.99	-0.91	-0.75	-0.74	-0.74
Net Debt / EBITDA Ratio	1.28	1.57	0.93	1.15	1.44	1.63
Net Debt / FCF Ratio	1.30	1.54	0.97	1.04	1.25	1.23
Asset Turnover	0.00	0	0.00	0.00	0.00	0.00
Quick Ratio	9.19	10.25	3.41	6.66	7.59	12.37
Current Ratio	9.50	10.64	3.98	7.09	8.10	14.29
Return on Equity (ROE)	-94.11%	-79.72%	-96.32%	-60.49%	-51.29%	45.88%
Return on Assets (ROA)	-45.01%	-40.21%	-43.54%	-32.74%	-32.80%	-36.95%
Return on Capital Employed (ROCE)	-68.40%	-56.40%	-83.20%	-62.30%	-53.40%	-45.30%
Earnings Yield	-9.04%	-10.93%	-9.27%	-13.82%	-9.23%	2.49%
FCF Yield	-8.90%	-11.57%	-8.38%	-14.57%	-11.40%	-4.71%
Buyback Yield / Dilution	-23.27%	-18.81%	-20.98%	-2.29%	-9.65%	-0.90%

Updated Nov 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.